https://stockisy.com/osia-hyper-retail-share-analysis-asset-bechkar-debt-chuka-rahi-company-promoter-holding-bhi-ghati/2026-06-02T05:27:25ZStockIsyenOsia Hyper Retail Share Analysis: Asset Bechkar Debt Chuka Rahi Company? Promoter Holding Bhi Ghati!2026-06-02T05:27:25ZBloghttps://stockisy.com/suven-life-sciences-share-analysis-revenue-gir-raha-hai-cash-flow-negative-biotech-story-ya-risky-bet/2026-06-02T04:26:46ZStockIsyenSuven Life Sciences Share Analysis: Revenue Gir Raha Hai, Cash Flow Negative! Biotech Story Ya Risky Bet?2026-06-02T04:25:21ZBloghttps://stockisy.com/zuari-industries-ka-sach-ebitda-margin-gir-gaya-profit-sirf-other-income-se/2026-06-02T04:28:11ZStockIsyenZuari Industries Ka Sach! EBITDA Margin Gir Gaya, Profit Sirf Other Income Se?2026-06-02T04:12:05ZBloghttps://stockisy.com/brightcom-group-share-analysis-78-revenue-ka-paisa-abhi-tak-company-ko-nahi-mila-kya-ye-bada-red-flag-hai/2026-06-02T04:37:32ZStockIsyenBrightcom Group Share Analysis: 78% Revenue Ka Paisa Abhi Tak Company Ko Nahi Mila! Kya Ye Bada Red Flag Hai?2026-06-02T03:43:24ZBloghttps://stockisy.com/transchem-share-price-rally-revenue-zero-hone-ke-baad-bhi-stock-kyu-bhaag-raha-hai/2026-06-02T04:41:33ZStockIsyenTranschem Share Price Rally: Revenue Zero Hone Ke Baad Bhi Stock Kyu Bhaag Raha Hai?2026-06-01T06:15:32ZBloghttps://stockisy.com/mercury-laboratories-analysis-revenue-growth-zero-pharma-stock-me-kya-hai-risk/2026-06-02T04:43:47ZStockIsyenMercury Laboratories Analysis: Revenue Growth Zero, Pharma Stock Me Kya Hai Risk?2026-06-01T05:53:29ZBloghttps://stockisy.com/ccme-global-analysis-company-ya-jaal-investors-ke-liye-badi-warning/2026-06-02T04:45:02ZStockIsyenCCME Global Analysis: Company Ya Jaal? Investors Ke Liye Badi Warning2026-06-01T05:32:02ZBloghttps://stockisy.com/albert-david-profit-ka-khel-core-business-kamzor-other-income-se-positive-bottom-line/2026-06-02T05:06:29ZStockIsyenAlbert David Profit Ka Khel? Core Business Kamzor, Other Income Se Positive Bottom Line!2026-06-01T04:53:30ZBloghttps://stockisy.com/sakuma-exports-analysis-sales-giri-ebitda-margin-0-ke-paas-opportunity-ya-red-flag/2026-06-02T05:12:15ZStockIsyenSakuma Exports Analysis: Sales Giri, EBITDA Margin 0% Ke Paas Opportunity Ya Red Flag?2026-06-01T03:52:03ZBlog